Beck Bode LLC’s Chemours CC Stock Holding History

Beck Bode LLC’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100	Closed	-$3K	–	118
2021 Q2	$3K	Buy	+100	New	+$3.31K	﹤0.01%	287
2020 Q4	–	Sell	-100	Closed	-$2K	–	46
2020 Q3	$2K	Buy	+100	New	+$1.93K	﹤0.01%	284

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Beck Bode LLC's CC Position: Q3 2021 in Review

Beck Bode LLC sold out of Chemours (CC) in Q3 2021, closing a stake of 100 shares — an estimated $3K sold.

Beck Bode LLC first reported a position in CC in Q3 2020 and held it in 2 quarters. The position peaked at $3K in Q2 2021. 461 funds tracked by Wall St. Rank hold CC as of Q3 2021.

Beck Bode LLC reported no remaining Chemours position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 100 Chemours shares in Q3 2021, an estimated $3K.
Beck Bode LLC first reported a position in Chemours in Q3 2020 and held it in 2 quarters.
Beck Bode LLC's Chemours position peaked at $3K in Q2 2021.
461 funds tracked by Wall St. Rank held Chemours as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.